• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.关于人类脊髓灰质炎主动免疫的研究。II. 诱导和维持抗体形成的实用方法。
Am J Public Health Nations Health. 1954 Aug;44(8):994-1009. doi: 10.2105/ajph.44.8.994.
2
[Examinations on poliomyelitis antibodies in the population and the practical significance of antibody determination in poliomyelitis vaccination].[人群中脊髓灰质炎抗体检测及脊髓灰质炎疫苗接种中抗体测定的实际意义]
Monatsschr Kinderheilkd (1902). 1956 Mar;104(3):135-6.
3
[The formation of neutralizing antibodies in humans after poliomyelitis immunization with the Behring vaccine].[使用贝林疫苗进行脊髓灰质炎免疫后人体中中和抗体的形成]
Dtsch Med Wochenschr. 1955 Sep 16;80(37):1329-31. doi: 10.1055/s-0028-1116195.
4
[Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].[婴儿在初次基础免疫后5至6个月接种索尔克型脊髓灰质炎疫苗“加强”剂量后的抗体反应]
Pediatria (Napoli). 1961 Sep-Oct;69:851-6.
5
Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies.用减毒活脊髓灰质炎病毒对婴儿进行免疫；对6个月以下具有先天性获得性抗体的婴儿进行消化道感染及抗体反应的实验室研究。
J Am Med Assoc. 1956 Dec 1;162(14):1281-8.
6
A method for the rapid determination of immunogenic potency of poliomyelitis vaccines by single vaccination of white rats.一种通过对白鼠进行单次接种来快速测定脊髓灰质炎疫苗免疫原性效力的方法。
Acta Virol. 1959 Oct;3:250-2.
7
[Virus excretion and antibody formation after double oral poliomyelitis vaccination (Cox triple vaccine and Sabin vaccine)].[口服两次脊髓灰质炎疫苗（柯克斯三联疫苗和萨宾疫苗）后的病毒排泄与抗体形成]
Ann Paediatr. 1962;199:245-9.
8
The antibody response to poliomyelitis vaccine in school-children at the time of initial vaccination and one year later.
Can J Public Health. 1957 Mar;48(3):96-100.
9
The relationship between specific skin reaction and neutralizing antibody titers in the young infant following immunization with poliomyelitis (Salk-type) vaccine.小儿麻痹症（索尔克型）疫苗免疫后，幼儿特定皮肤反应与中和抗体滴度之间的关系。
Ann Paediatr. 1961;196:389-98.
10
Observations on the complement-fixing antibody response in human poliomyelitis. Influence of age and vaccination status.
J Immunol. 1962 Sep;89:358-66.

引用本文的文献

1
Cryopreservation of Cell Sheets for Regenerative Therapy: Application of Vitrified Hydrogel Membranes.用于再生治疗的细胞片冷冻保存：玻璃化水凝胶膜的应用
Gels. 2023 Apr 10;9(4):321. doi: 10.3390/gels9040321.
2
Noninvasive vaccination against infectious diseases.非侵入性传染病疫苗接种。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1717-1733. doi: 10.1080/21645515.2018.1461296. Epub 2018 May 17.
3
Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.氧固醇结合蛋白家族 I 是微量类似 enviroxime 化合物的靶标。
J Virol. 2013 Apr;87(8):4252-60. doi: 10.1128/JVI.03546-12. Epub 2013 Jan 30.
4
Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection.包涵体蛋白 (VCP/p97) 是脊髓灰质炎病毒复制所必需的，并且在脊髓灰质炎病毒感染中涉及细胞蛋白分泌途径。
J Virol. 2012 May;86(10):5541-53. doi: 10.1128/JVI.00114-12. Epub 2012 Feb 29.
5
Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity.磷脂酰肌醇 4-激酶 IIIβ是抗脊髓灰质炎病毒活性类似依维莫司化合物的靶标。
J Virol. 2011 Mar;85(5):2364-72. doi: 10.1128/JVI.02249-10. Epub 2010 Dec 22.
6
Lessons from the Salk polio vaccine: methods for and risks of rapid translation.索尔克脊髓灰质炎疫苗的教训：快速转化的方法和风险。
Clin Transl Sci. 2010 Aug;3(4):182-5. doi: 10.1111/j.1752-8062.2010.00205.x.
7
A Color Test for Poliomyelitis.一种用于脊髓灰质炎的颜色检测法。
Am J Public Health Nations Health. 1954 Dec;44(12):1581-2. doi: 10.2105/ajph.44.12.1581.
8
The penicillin content of poliomyelitis vaccine (Salk) and its administration to allergic patients.脊髓灰质炎疫苗（索尔克氏疫苗）中的青霉素含量及其对过敏患者的施用。
Am J Public Health Nations Health. 1955 Jun;45(6):791-2. doi: 10.2105/ajph.45.6.791.
9
Present status of the problem of vaccination against poliomyelitis.脊髓灰质炎疫苗接种问题的现状
Am J Public Health Nations Health. 1955 Mar;45(3):285-97. doi: 10.2105/ajph.45.3.285.
10
Observations on natural poliovirus infections in immunized children.关于免疫儿童自然脊髓灰质炎病毒感染的观察
Am J Public Health Nations Health. 1957 Apr;47(4 Pt 1):421-31. doi: 10.2105/ajph.47.4_pt_1.421.

本文引用的文献

1
Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines.实验性脊髓灰质炎疫苗的甲醛处理及安全性测试
Am J Public Health Nations Health. 1954 May;44(5):563-70. doi: 10.2105/ajph.44.5.563.
2
Recent studies on immunization against poliomyelitis.近期关于脊髓灰质炎免疫接种的研究。
Pediatrics. 1953 Nov;12(5):471-82.
3
Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress.关于人类脊髓灰质炎主动免疫的研究。一、正在进行的实验的初步报告。
J Am Med Assoc. 1953 Mar 28;151(13):1081-98.

Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.

作者信息

SALK J E, BAZELEY P L, BENNETT B L, KRECH U, LEWIS L J, WARD E N, YOUNGNER J S

出版信息

Am J Public Health Nations Health. 1954 Aug;44(8):994-1009. doi: 10.2105/ajph.44.8.994.

DOI:10.2105/ajph.44.8.994
PMID:13180761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1620864/
Abstract
摘要